Member Info for inanaco

please advise this BB regarding any negative thats based on fact not speculation regarding SCLP

please advise this BB regarding any negative thats based on fact not speculation regarding SCLP

If shareholders on any BB get tips from others .. whats wrong with that ? it happens all the time ... nobody is stopping you trying to deramp Scancell ? you cant have it both ways ... thats why its checks and balance.

agree mate cancer is the number 1 target ... regardless in my book... my point was related to value, i say no more. i have read up on there approach mainly in the potential halt of spread of the cancer by control of signal paths, then i believe the next trial is to add chemo to stop cell division to induce death of the tumour. anyway best of luck with the trials and i hope patients remain stable.

whats all this hint then ? i also started with Am i to understand .... so you are saying there is No bid in the air ? and others posting is there guess work from your hint ...

Am I to understand you think that there is a bid to buy this stock at £1.8 billon pounds ? sorry but your market Cap now stands at £110 million pounds with a SP at 5.5p how is it going to jump to that valuation .. what has SLN got that could generate that sort of Mcap .. what income stream is expected. What is the BOD going to do with that income stream ?? the list goes on and on, Not trying to deramp the share but would love to know how you come to your valuation of SLN .. Riddler pointed this out before, but i have not seen your take on it.

Well Scancell's SCIB1 being a vaccine as you say will have the extra power to create an immune response and an immune memory against melanoma. This should therefore prevent melanoma recurring in patients who have had their tumours surgically removed as it will be doing in Phase 2. So yes the uses and widespread capabilities of SCIB1 are potentially far superior to any pathway inhibitor, be it Dabrafenib, Yervoy or anything else

http://www.eacr.org/pivac12/downloads/PIVAC12%20Complete%20Programme%20Book.pdf

i gave up ... on the research, however will look in here in the new year .. if they can keep increasing there market share, then you may see some serious money coming in... its on my target list .. earnings ratio still a little to high at the moment and the uk is still slowing, so if they can ride the wave with increasing turnover it will bode well for 2013.best of luck holders ...

i just looked at the accounts .. also take out the intangible assets .. the debts are high but they seem to be able to service them, but i must admit with that level of debt it changes things around as the banks could control this rather than the directors .. one hiccup ... PFD ... Hamp ... list goes on ... still a buy at this level IMHO

are you joining the club ?

uk construction although negative at present is the only sector the goverment primes to get the economy moving expect more pumping not less .. so there neg statement regarding construction should turn pos over the next 6 months.. but again Europe is the driving force.

Yoda .. was dragged down on the slowing of the uk and OIL price has a direct impact due to Haulage and storage as its main business model.. Oil prices came down a tad which helps the bottem line, and with expected release of reserves from the US .. crude is becoming more stable, has secured new and renewed contracts inc R royce.. yields 17% approx .. UK continues to drive for growth and with the headline negative changing from .7 to .5 expect the bottem is near. cant go on forever as things wear out .. so a natural swing in the economy will happen and any change for the better in Europe will have a direct impact on the bottem line .. my rec. is BUY target £1.30

anyone know when the Helium fund sold out of this baby ? cant see it on the RNS ...

looks like we have links here with SCLP via the Helium fund, will do some research

Gemfields plc (AIM: GEM) presents an operational update for the three month period and year ending 30 June 2012. All figures are approximate, unaudited and, unless otherwise stated, the phrase "carats" includes both emerald and beryl. Highlights Production summary for the Kagem emerald mine: The final quarter of the year saw strong production growth to 7.3 million carats (versus 4.9 million carats in the prior quarter); Grade for the quarter was 181 carats per tonne (versus 236 carats per tonne in the prior quarter), with unit production costs of USD 0.57 per carat (versus USD 0.85 per carat in the prior quarter) Cash rock handling unit cost were USD 3.5 per tonne (versus USD 3.7 per tonne in the prior quarter) Unit ore production costs reduced by 48% from USD 200 per tonne in the prior quarter to USD 104 per tonne Kagem's large-scale on-going waste movement programme is progressing well to open up new areas for future ore production Revenue of USD 9.0 million from successful Jaipur auction of 3.47 million carats in June 2012 At 30 June 2012, Gemfields had USD 36.7 million in cash and debt outstanding of USD 2.9 million The Montepuez ruby mine in Mozambique is on track to commence bulk sampling in the coming quarter Demand for ethical emeralds continues to remain firm across all major markets with Gemfields' next higher quality rough emerald auction scheduled to take place in Singapore between the 29 October and 3 November 2012

do u like that ?

but u sold some at 19.6 approx because you was bored ?

Thorntons should remain just that... The UK has sold off most of its Gems, lets try and keep the few we have left.

i think MM are following my maths opps